发明授权
EP2526771B1 Inhibitors of bruton's tyrosine kinase 有权
Hammer der Bruton-Tyrosinkinase

Inhibitors of bruton's tyrosine kinase
摘要:
Disclosed herein are compounds that form covalent bonds with Bruton's tyrosine kinase (Btk). Also described arc irreversible inhibitors of Btk. Methods for the preparation of the compounds are disclosed. Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the Btk inhibitors are disclosed, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions.
公开/授权文献
信息查询
0/0